Financing health innovation: blended capital models for scalable impact

Africa’s health transformation requires more than groundbreaking technology - it requires the financing models able to sustain, scale, and replicate it.

Whether it’s smart hospitals, AI-enabled diagnostics, pharmaceutical localisation, or digital health platforms, the continent’s most promising innovations struggle not because of scientific limits, but because of financing gaps.

Traditional grants are too short-term. Commercial capital is often too risk-averse. Government budgets are stretched.

The answer, increasingly, lies in blended capital - the strategic combination of public, private, philanthropic and development finance that reduces risk, crowds in investment, and accelerates impact.

As Morocco prepares to host GITEX FUTURE HEALTH AFRICA 2026, the continent is shifting from pilot projects to long-term, investable health solutions. At the centre of this shift is a new financial architecture designed specifically for Africa’s evolving health economy.

Why Africa needs blended capital for health innovation

The funding gap for healthcare in Africa is enormous.

David R. Malpass, former President of the World Bank estimates that the financing gap for the world’s 54 poorest countries - including many African countries - is $176 billion annually. Meanwhile, the African Development Bank (AfDB) notes that local health systems suffer from fragmented investments that struggle to scale.

Blended finance solves key structural barriers:

1. High perceived risk

Political uncertainty, currency volatility and limited guarantees deter investors.

2. Small ticket sizes

Most African health innovations are too small for institutional investors - yet too capital-intensive for local banks.

3. Long payback periods

Health infrastructure, pharmaceuticals and insurance reforms take years to mature.

4. Weak early-stage funding

Health startups receive less than 10% of Africa’s annual VC funding.

Blended capital de-risks early stages and unlocks scalability.

Morocco: blended finance as a strategic engine for health reform

Morocco is one of the continent’s clearest examples of how public-private-philanthropic alignment can drive health innovation.

1. Sovereign funds anchoring large-scale projects

Morocco’s sovereign investment vehicles co-invest with private actors in hospital infrastructure, pharmaceutical manufacturing and biotech

2. PPPs for health infrastructure and digital systems

The government’s 2023–2027 Health Reform Charter enables PPPs for:

• regional hospitals,
• diagnostic centres,
• telemedicine networks,
• and digital patient records (DMP).

3. Insurance reform unlocking health financing

Morocco’s universal insurance expansion—covering over 90% of citizens—creates predictable reimbursement flows that attract investors and improve hospital revenue cycles.

4. Partnerships with development finance institutions (DFIs)

The country collaborates with the IFC, AfDB, EIB, and UNIDO on pharmaceutical localisation, supply-chain modernisation and smart-hospital readiness. These foundations make Morocco an ideal host for investment-focused discussions at GITEX FUTURE HEALTH AFRICA 2026.

How blended finance works: four models shaping Africa’s health economy

1. Public + DFI + Private (triangular model)

The most common model combines government guarantees, DFI risk-sharing, and private capital.

Example:

• NSIA (Nigeria Sovereign Investment Authority) , IFC, the Ministry of Health created diagnostic and cancer centres across Nigeria, with notable outcomes being equipment upgrades, reduced waiting times, and improved cancer screening.

2. Impact-first blended vehicles

Philanthropic funds absorb early risk, unlocking commercial investment.

Example:

• HealthTech Africa Fund (Gates Foundation, IFC) supports startups in telemedicine, supply chains and AI diagnostics.

3. PPPs for infrastructure & service delivery

PPPs are heavily used for hospitals, labs, emergency services, and digital systems.

Example:

• Egypt’s UHIA PPP Model for universal health insurance, hospital upgrades and imaging centres.

4. Blended R&D models for pharmaceutical localisation

Africa’s pharmaceutical localisation efforts rely on:

• concessional loans,
• grant-funded R&D,
• sovereign capital,
• private manufacturing investment.

Example:

• Africa CDC PAVM (Partnership for African Vaccine Manufacturing) blends public subsidies, philanthropic funds and private expertise.

Case studies: where blended capital is already transforming health

Morocco - hospital infrastructure + pharmaceuticals

Hospital construction, digitalization of the ‘Dossier Médical Partagé’ (shared medical record), Vaccine-production partnerships, expansion of diagnostic centres… these initiatives are jointly financed by the government, sovereign wealth funds, Development Finance Institutions (DFIs), and private firms.

Rwanda - pandemic preparedness & digital health

DFI grants, private logistics firms and government frameworks enabled drone-based medical delivery (Zipline), genomic-surveillance labs, and the progress of national digital health systems in the country.

Kenya – digital-first primary care financing

Kenya’s UHC reforms create reimbursement certainty, helping investors fund initiatives such as M-TIBA health wallets, diagnostic hubs, and telemedicine networks.

South Africa – biomedical engineering & AI investments

Private capital and research grants fund AI radiology, SMART hospital systems and medical-device manufacturing.

Egypt – PPP-powered universal health insurance rollout

Egypt’s UHIA uses blended financing to modernise hospitals, imaging networks and e-claims

However, some notable obstacles are to consider to make room for scalable investment.

The barriers blocking scalable investment

1. Currency risk

Foreign investors hesitate due to FX volatility; hedging tools remain limited.

2. Regulatory fragmentation

The African Medicines Agency (AMA) is at an early stage in its efforts towards harmonisation. The establishment of the AMA is a critical step for the continent, aiming to standardise the regulation of medicines and health products across all member states. This harmonisation is intended to streamline the approval process, improve market access for essential medicines, and ensure higher quality, safety, and efficacy standards for products available to African populations. Achieving full harmonisation will require significant collaboration, capacity building, and the development of a unified regulatory framework that respects the diverse legal and health systems across Africa.

3. Small and inconsistent deal pipelines

Coordinated, multi-year investment pipelines for health are rarely presented by countries, which makes it challenging for both domestic and international stakeholders to plan, mobilize resources, and ensure sustained funding for long-term health system goals and initiatives.

4. Limited local institutional investors

African pension funds remain under-invested in health infrastructure and innovation.

What blended capital makes possible

When structured well, blended finance can accelerate hospital modernisation, local production of pharmaceuticals, supply-chain resilience, digital transformation, health security & early warning systems, AI, robotics & precision medicine adoption. It moves health systems from pilot projects to national-scale implementation.

Toward GITEX FUTURE HEALTH AFRICA 2026: the investment agenda

At GITEX FUTURE HEALTH AFRICA 2026 in Morocco, blended finance will be one of the most strategic themes discussed.

Expected sessions include:

• sovereign and private co-investment for smart hospitals,
• regional blended funds for pharma and diagnostics,
• digital health investment frameworks,
• PPP best practices,
• risk-sharing tools for innovative AI and robotics projects,
• ESG-linked health financing.

Conclusion

Africa’s health transformation cannot be achieved by governments or the private sector alone. Blended finance offers a roadmap for leveraging the strengths of both - public accountability with private efficiency, development-driven goals with commercial discipline.

Morocco’s 2030 Vision, strong regulatory reforms and investment ecosystem make it an ideal host for a continental conversation about financing innovation at scale.

As Africa prepares for the next decade of health innovation, GITEX FUTURE HEALTH AFRICA 2026 will bring together the investors, innovators and policymakers capable of turning ideas into action - and pilots into lasting impact.